MINISTERIO DA SAUDE

Their core work

Portugal's Ministry of Health is the national public authority responsible for health policy, public health surveillance, and population health data infrastructure. In EU research projects, they contribute national health survey data, biomonitoring samples, and epidemiological expertise — serving as the government-level data provider and policy bridge that connects research findings to actual public health decisions. Their involvement spans chemical exposure monitoring, childhood obesity policy, COVID-19 surveillance networks, and pandemic preparedness, always in the role of providing real-world health system access and national-level data.

What they specialise in

How they've shifted over time

In the earlier period (2015–2018), the Ministry focused on foundational health research infrastructure — cardiovascular disease research networks (ERA-CVD), chemical biomonitoring (HBM4EU), and childhood obesity policy (STOP). From 2020 onward, their focus shifted sharply toward infectious disease surveillance and pandemic response, with projects like I-MOVE-COVID-19, PHIRI, and PANDEM-2 all addressing COVID-19 or future pandemic preparedness. This pivot reflects both the global health crisis and a broader institutional move from chronic disease monitoring toward real-time health data infrastructure and crisis response capabilities.

Moving toward real-time population health data systems and pandemic preparedness — likely to seek future collaborations in health data interoperability, digital surveillance tools, and crisis response frameworks.

How they like to work

The Ministry of Health never coordinates projects — it participates as a data provider and national authority, including twice as a third party (HBM4EU, PANDEM-2), suggesting it provides specific national datasets or advisory input rather than leading research activities. With 207 unique partners across 41 countries, their network is remarkably broad for just 6 projects, which is typical for large-scale EU health infrastructure initiatives with 30+ consortium members each. They are a low-maintenance but valuable partner: they bring government-level legitimacy and national health data access without requiring heavy project management.

Despite only 6 projects, they have collaborated with 207 unique partners across 41 countries — a consequence of participating in very large pan-European health consortia. Their network spans virtually all EU member states and associated countries, with no narrow geographic focus.

What sets them apart

As a national ministry rather than a research institute, they offer something most partners cannot: direct access to Portugal's national health system data, official health surveys, and the authority to implement research findings into policy. For consortium builders, including them signals government buy-in and ensures that project results have a clear pathway to real-world policy impact. Few organizations can simultaneously provide population-level health data and serve as the end-user of research recommendations.

Highlights from their portfolio

• PHIRI
  Their largest funded project (EUR 322,711), building a population health information research infrastructure that became critical during the COVID-19 pandemic for cross-country health data comparisons.
• HBM4EU
  Europe's flagship human biomonitoring initiative — one of the largest H2020 health projects — where the Ministry contributed national exposure data on chemical mixtures and endocrine disruptors.
• PANDEM-2
  Forward-looking pandemic preparedness project combining simulation, IT systems, and response planning — signals the Ministry's strategic direction toward crisis readiness.